Trademark: 90846005
Status Date
Monday, March 11, 2024
Filing Date
Friday, July 23, 2021
Published for Opposition
Tuesday, January 24, 2023
42 Medical and scientific research in the field of Oligonucleotide-Based Medicines; Oligonucleotide-Based drug development services; engineering and chemical synthesis of oligonucleotide-based medicines and their building blocks and delivery technologies; engineering and chemical synthesis of oligonucleotide therapeutics and their building blocks and delivery technologies; experimental assessment of pharmacological and chemical properties of oligonucleotide-base medicines in the nature of pharmaceutical research and development; designing clinical trial studies for others; providing medical and scientific research information in the fields of Oligonucleotide-Based Medicine clinical trials; platform as a service (PaaS) featuring computer software platforms for data creation and collection using artificial intelligence for precision medicine, namely, to decode diseases, develop targeted Oligonucleotide-Based Medicine treatments and therapies, and to select patients that will respond to Oligonucleotide-Based Medicine treatments and therapies; platform as a service (PaaS) featuring computer software platforms for data creation and collection using artificial intelligence for big data analytics, predictive data analytics, and predictive modeling, and multivariate analytics; platform as a service (PaaS) featuring data creation and collection tools, computer platforms and software using artificial intelligence for bioinformatics, simulations in clinical trials or studies, the designing of clinical trials or studies, and the de-risking of clinical trial or study designs and clinical trials simulations
Mar 12, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 11, 2024
Sou Extension 2 Granted
Mar 11, 2024
Sou Extension 2 Filed
Mar 11, 2024
Sou Teas Extension Received
Sep 22, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 20, 2023
Sou Extension 1 Granted
Sep 20, 2023
Sou Extension 1 Filed
Sep 20, 2023
Sou Teas Extension Received
Sep 15, 2023
Teas Change Of Correspondence Received
Sep 15, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 15, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 21, 2023
Noa E-Mailed - Sou Required From Applicant
Jan 24, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 24, 2023
Published For Opposition
Jan 4, 2023
Notification Of Notice Of Publication E-Mailed
Dec 19, 2022
Approved For Pub - Principal Register
Nov 11, 2022
Teas/Email Correspondence Entered
Nov 11, 2022
Correspondence Received In Law Office
Nov 11, 2022
Teas Response To Office Action Received
May 12, 2022
Notification Of Non-Final Action E-Mailed
May 12, 2022
Non-Final Action E-Mailed
May 12, 2022
Non-Final Action Written
Apr 18, 2022
Assigned To Examiner
Sep 23, 2021
New Application Office Supplied Data Entered
Jul 27, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
